PBR Nachrichten

PBR (Pharmaceutical Business Review) ist ein Onlineportal mit News zur Pharma- und Biotechnologiebranche. Die Redaktion berichtet über neue Medikamente und deren Zulassungsverfahren, sowie über geschäftliche Entwicklungen von Pharmaunternehmen.
 
18.10.19 - 12:39
Trastuzumab deruxtecan granted FDA priority review to treat patients with HER2-positive metastatic breast cancer (PBR)
 
The Prescription Drug User Fee Act (PDUFA) date for trastuzumab deruxtecan, a HER2-targeting antibody drug conjugate (ADC) and potential new medicine for the treatment of HER2-positive metastatic breast The post Trastuzumab deruxtecan granted FDA pr...
18.10.19 - 11:15
Horizon Therapeutics initiates PROTECT clinical trial of KRYSTEXXA (pegloticase injection) (PBR)
 
Horizon Therapeutics has initiated an open-label clinical trial evaluating the use of KRYSTEXXA (pegloticase injection) in adults with chronic gout refractory to conventional therapies - also known as The post Horizon Therapeutics initiates PROTECT ...
18.10.19 - 10:15
FDA approves Roche′s Xofluza for patients at high risk of developing flu-related complications (PBR)
 
The FDA has approved the company's supplemental new drug application (sNDA) for Xofluza to treat acute, uncomplicated influenza, or flu, in people 12 years of age and older The post FDA approves Roche's Xofluza for patients at high risk of develop...
17.10.19 - 11:52
Boehringer Ingelheim enrols first patient in Phase II BALANCE-CFTM 1 study (PBR)
 
The trial will investigate how different doses of the compound, an inhaled epithelial sodium channel (ENaC) inhibitor, impact lung function compared to placebo when added to the standard The post Boehringer Ingelheim enrols first patient in Phase II...
17.10.19 - 11:27
TriPharm Services announces creation of pharmaceutical manufacturing center (PBR)
 
The center of excellence specializes in injectable pharmaceutical capabilities including flexible manufacturing solutions for liquid and lyophilized products. The facility, located at 627 Davis Drive in Morrisville and The post TriPharm Services ann...
17.10.19 - 09:27
Alexion to buy clinical-stage biopharmaceutical firm Achillion for $930m (PBR)
 
Achillion is involved in the development of oral small molecule Factor D inhibitors for the treatment of people with complement alternative pathway-mediated rare diseases such as paroxysmal nocturnal The post Alexion to buy clinical-stage biopharmac...
16.10.19 - 14:51
CRISPR, KSQ Therapeutics join forces to advance cell therapies in oncology (PBR)
 
The agreement allows CRISPR, a Swiss gene editing company, to gain access to the KSQ Therapeutics' intellectual property (IP) for editing certain gene targets in its allogeneic oncology The post CRISPR, KSQ Therapeutics join forces to advance cell ...
16.10.19 - 12:27
Trialbee and TriNetX partner to accelerate patient-centric clinical trials (PBR)
 
"This partnership will significantly widen Trialbee's service offerings to drive patient recruitment and retention, said Lollo Eriksson, CEO of Trialbee. "This is a great opportunity to leverage both The post Trialbee and TriNetX partner to accele...
16.10.19 - 11:50
Sun Pharma launches Drizalma Sprinkle in US (PBR)
 
Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor (SNRI) designed for the treatment of various neuro-psychiatric and pain disorders in patients who have difficulty swallowing - a The post Sun Pharma launches Drizalma Sprinkle in...
16.10.19 - 10:39
Acino to buy Takeda’s select OTC and prescription pharmaceutical assets for $200m (PBR)
 
The divestment is part of Takeda's strategy to focus on core business areas and facilitate rapid deleveraging following its acquisition of Shire. Takeda growth and emerging markets business The post Acino to buy Takeda’s select OTC and prescr...
15.10.19 - 15:39
Thermo Fisher launches IonicX XRF Analyzer to identity ionic salts (PBR)
 
According to the life sciences company, the technology used by the IonicX XRF Analyzer helps save time and money that is otherwise used on conventional analysis techniques. This The post Thermo Fisher launches IonicX XRF Analyzer to identity ionic s...
15.10.19 - 13:13
Kyowa Kirin launches NOURIANZ in US for treatment of Parkinson′s disease "Off episodes (PBR)
 
Over time, patients taking levodopa may begin to experience periods when PD symptoms, including motor fluctuations, re-emerge between treatment doses. These are called "off episodes. "We are pleased The post Kyowa Kirin launches NOURIANZ in US for ...
15.10.19 - 11:40
Forbius completes enrollment into phase 1a solid tumour trial of AVID200 (PBR)
 
Simultaneously, the company completed a Series C financing led by HBM Partners with participation from new and existing investors. AVID200 is rationally designed to selectively and potently inhibit The post Forbius completes enrollment into phase 1a...
15.10.19 - 10:27
Janssen, Bayer get FDA nod for Xarelto to prevent VTE in acutely ill medical patients (PBR)
 
The approval has been granted for Xarelto to prevent venous thromboembolism (VTE) or blood clots in hospitalised acutely ill medical patients at risk for thromboembolic complications who are The post Janssen, Bayer get FDA nod for Xarelto to prevent...
14.10.19 - 15:27
MabThera meets primary endpoint in PEMPHIX trial in pemphigus vulgaris (PBR)
 
The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the late-stage trial held in adult patients. PEMPHIX has been taken up by Roche The post MabThera meets primary endpoint in PEMPHIX trial in pemphigus vulgari...
14.10.19 - 12:40
Pfizer presents positive phase 3 data for abrocitinib in moderate to severe atopic dermatitis (PBR)
 
Abrocitinib, an investigational oral Janus kinase 1 (JAK1) inhibitor, met all the co-primary and key secondary endpoints, which were related to skin clearance and itch relief compared to The post Pfizer presents positive phase 3 data for abrocitinib...
14.10.19 - 11:15
Sun Pharma launches CEQUA for treatment of dry eye disease in US (PBR)
 
CEQUA, which offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration (FDA), is indicated to increase tear production in patients The post Sun Pharma launches CEQUA for treatment of dry ey...
14.10.19 - 10:15
Eli Lilly gets FDA approval for migraine drug Reyvow (PBR)
 
Reyvow is a new oral medication for the acute treatment of migraine, with or without aura, in adults. It binds to 5-HT1F receptors with high affinity. Reyvow is The post Eli Lilly gets FDA approval for migraine drug Reyvow appeared first on Pharmace...
11.10.19 - 12:51
Gilead, Galapagos announce 52-week results of filgotinib in FINCH 1, FINCH 3 studies in rheumatoid arthritis (PBR)
 
"We are encouraged by the durability of both the efficacy and safety profiles of filgotinib seen in these studies, said John Sundy, MD, PhD, Senior Vice President, Inflammation The post Gilead, Galapagos announce 52-week results of filgotinib in FI...
11.10.19 - 12:27
Belgium′s UCB to buy Ra Pharmaceuticals for $ 2.1bn (PBR)
 
Under the deal, Ra Pharmaceuticals shareholders will secure $48 in cash for each of its share at closing. Based in Cambridge of Massachusetts, Ra Pharma uses an advanced The post Belgium's UCB to buy Ra Pharmaceuticals for $ 2.1bn appeared first on...
>Zitat des Tages: Tue was du für recht hältst, wenn du auch deswegen nicht öffentlich gelobt würdest; denn die Welt ist ein schlechter Richter über gute Taten. - Matthias Claudius
Partner:    >Tradegate Börse | >DB Xmarkets | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy

Börsentreff auf Facebook | Börsentreff auf Twitter

Copyright @ Boersentreff.de - Die Märkte im Blick!